HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Comparing Eyetuck To Surgery Is More Than Mere Puffery – NAD

This article was originally published in The Rose Sheet

Executive Summary

Skin Doctors Cosmeceuticals should "limit its performance claims to the efficacy of the ingredient Eyeseryl" when touting its Eyetuck Anti-Bag Technology product for potential reduction of under eye puffiness, the National Advertising Division (NAD) concludes in an upcoming Case Reports

You may also be interested in...



NAD Finds Wrinkle In University Medical Advertising For Botox Alternative

The National Advertising Division recommends in a May 15 report that University Medical Pharmaceuticals modify print advertising claims promoting its WrinkleFree At Home Wrinkle Reversal System as a replacement for Botox and Restylane

NAD Finds Wrinkle In University Medical Advertising For Botox Alternative

The National Advertising Division recommends in a May 15 report that University Medical Pharmaceuticals modify print advertising claims promoting its WrinkleFree At Home Wrinkle Reversal System as a replacement for Botox and Restylane

NAD Remains On The Lookout For Performance Claims That Exceed Puffery

The National Advertising Division of the Council of Better Business Bureaus will continue to watch for quantified and comparison-based performance claims within the increasingly sophisticated cosmetics marketplace, according to Director Andrea Levine

Related Content

UsernamePublicRestriction

Register

RS014565

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel